Search Results - "Falkson C"

ASO Author Reflections: The Number of Involved Structures is a Promising Prognostic Factor in Thymic Epithelial Tumors.

Authors: Chiappetta M Lococo F Sassorossi C et al.

Source: Annals of surgical oncology [Ann Surg Oncol] 2024 Jul; Vol. 31 (7), pp. 4327-4328. Date of Electronic Publication: 2024 Apr 20.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Development of a validated LC-ESI-MS/MS method for the quantification of tucatinib in plasma samples.

Authors: Pawar, Sunil Dattatray Kayande, Deepak D. Pawar, Kokila et al.

Source: Journal of Applied Pharmaceutical Science. May2026, Vol. 16 Issue 5, p169-175. 7p.

Author Index.

Source: Quality of Life Research. Oct2000, Vol. 9 Issue 10, p1155-1158. 4p.

Subjects: Periodical indexes, Authors, Quality of Life Research (Periodical)

Real-Time Therapy Response Monitoring Using Surface Biomarkers on Circulating Tumor Cells.

Authors: Andhari, Saloni Farmaha, Jaspreet Vashisht, Ashutosh et al.

Source: Cancers. Feb2026, Vol. 18 Issue 3, p391. 19p.

The Rare Entity of Basaloid Thymic Carcinoma: A Multicentric Retrospective Analysis from the Italian Collaborative Group for ThYmic MalignanciEs (TYME).

Authors: Catania, Chiara Manglaviti, Sara Zucali, Paolo et al.

Source: Cancers. Jan2025, Vol. 17 Issue 2, p239. 10p.

Recurrence Patterns, Treatment Outcomes, and Prognostic Factors of Thymic Carcinoma: A Multicenter Study.

Authors: Tomita, Natsuo Ishihara, Shunichi Nomoto, Yoshihito et al.

Source: Cancers. Aug2025, Vol. 17 Issue 15, p2513. 13p.

Guideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancer.

Authors: Falkson, C. B. Vella, E. T. Yu, E. et al.

Source: Current Oncology. Feb2017, Vol. 24 Issue 1, pe44-e49. 6p. 3 Charts.

Neoadjuvant Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy in Thymic Epithelial Tumors: A Propensity Score-Matched Analysis.

Authors: Na, Bubse Kang, Chang Hyun Yun, Taeyoung et al.

Source: Cancers. Jan2026, Vol. 18 Issue 1, p85. 15p.

Current Clinical Paradigm and Therapeutic Advancements in Thymic Malignancies: A Narrative Review.

Authors: Dias e Silva, Douglas Miyamura, Beatriz Viesser Mambetsariev, Isa et al.

Source: Cancers. Nov2025, Vol. 17 Issue 22, p3622. 21p.

Patterns of Management of Positive Sentinel Lymph Nodes in Breast Cancer Patients After the American College of Surgeons Oncology Group Z0011 Trial: A Retrospective Study.

Authors: El Charif, Mohamad Hadi Ghezzawi, Malak Kalot, Nour et al.

Source: Cancers. Nov2025, Vol. 17 Issue 22, p3621. 14p.

Will Minimal Residual Disease Monitoring Be Part of Routine Surveillance?

Authors: Pfister, Kerstin Schäffler, Henning Huesmann, Sophia et al.

Source: Oncology Research & Treatment. 2025, Vol. 48 Issue 6, p372-378. 7p.

Continuing Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Advanced Breast Cancer: A Meta-Analysis †.

Authors: Pathak, Neha Kumar, Sudhir Gimenez, Diego Malon et al.

Source: Cancers. May2025, Vol. 17 Issue 10, p1609. 15p.

Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials.

Authors: Trapani D Jin Q Miller KD et al.

Source: Clinical breast cancer [Clin Breast Cancer] 2025 Jun; Vol. 25 (4), pp. e419-e430.e5. Date of Electronic Publication: 2024 Dec 31.

Publication Type: Comparative Study; Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

Drug resistance to antibody-drug conjugates: mechanisms, challenges, and perspectives.

Authors: Liu, Yajing Liu, Yuwei Wu, Tingting et al.

Source: Cancer Biology & Medicine. Jun2026, Vol. 23 Issue 6, following p833-864. 35p.

Trends and Disparities in Secondary Malignant Neoplasms of the Bone in the United States: The WONDER Study.

Authors: Leach, Eileen Carlson, Andrew Tauseef, Abubakar et al.

Source: Cancers. Jun2026, Vol. 18 Issue 12, p1877. 15p.

Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer: A Literature Overview.

Authors: Gorzelak-Magiera, Anita Kabut, Jacek Sadurska, Joanna et al.

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1718. 20p.

Dual Biomarker Strategies for Liquid Biopsy: Integrating Circulating Tumor Cells and Circulating Tumor DNA for Enhanced Tumor Monitoring.

Authors: Moon, Ga Young Dalkiran, Basak Park, Hyun Sung et al.

Source: Biosensors (2079-6374); Feb2025, Vol. 15 Issue 2, p74, 23p

TNM Staging System in Thymoma: A Critical Appraisal?

Authors: Ambrogi, Marcello Carlo Aprile, Vittorio Lenzini, Alessandra et al.

Source: Journal of Clinical Medicine. Jan2024, Vol. 13 Issue 2, p610. 10p.

Predictive Value of Quantitative ADC, SUVmax, and the SUVmax/ADC Ratio for Biological Behavior and Prognosis in High-Risk Prostate Cancer.

Authors: Ataş, Abdullah Enes Kerimoğlu, Ülkü İlhan, Zeki et al.

Source: Journal of Clinical Medicine. Oct2025, Vol. 14 Issue 20, p7150. 16p.

Bone Targeted Parathyroid Hormone Antagonists for Prevention of Breast Cancer Bone Metastases.

Authors: Anbalagan, Muralidharan Ponnapakkam, Tulasi Zou, Binghao et al.

Source: Cancers. Sep2025, Vol. 17 Issue 17, p2933. 14p.